ARCHIVES

Von Eschenbach a “misguided choice” for FDA, House members write to HHS Secretary Leavitt. Conflicts inadequately addressed, they said.

This article is from The Cancer Letter archive.

Vol. 31 No. 37 | October 14, 2005

Download PDF Visit The Full Archive

Related Articles

Lymphoma Research Foundation names William Hawley president.

January 23, 2004

Komen Officials Say Charity is Stabilizing Despite 22 Percent Drop in Contributions

January 24, 2014

Drasga and Einhorn Respond to Single Payer Proposal Rebuttal

February 14, 2014

Surveillance Treatment Option For Low-Risk Prostate Cancer

July 30, 2010

NCI Begins TAILORx Study.

May 26, 2006

Advisors Discuss NCI Intramural Program In Closed Session, Defend Process

December 16, 1994